Artivion, Inc. (AORT) stock

AORTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 8/3023% above fair value

$19.40−0.70 (-3.48%)

Close on Nov 12, 2026Market cap $945.87MP/E –Yield –

Artivion statistics

94 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Feb 11, 2027 (estimated, during market hours)
Last ex-dividend date: Dec 9, 2015
Fundamentals through: Sep 30, 2026
Share price as of: Nov 12, 2026

Valuation ratiosIndustry

Market Cap: $945.87M; $501.02M
Enterprise Value: $1.26B; $422.54M
PS Ratio: 1.96; 3.03
PB Ratio: 2.12; 3.29
P/OCF Ratio: 63.52; 22.12

Enterprise valuationIndustry

EV / Sales: 2.62; 2.70
EV / EBITDA: 33.87; 18.53
EV / EBIT: 114.14; 24.04

Share statisticsIndustry

Shares Outstanding: 49M; 43M
Shares Change (YoY): 12.8%; 3.22%
Float: 44M; 37M
Shares Held by Insiders: 8.89%; 10.5%
Shares Held by Institutions: 94.9%; 60.2%

Short sellingIndustry

Short Interest: 3M; –
Short Interest Change: -8.65%; -2.57%
Short % of Float: 7.68%; 5.12%
Short % of Shares Outstanding: 7.00%; 3.98%
Days to Cover: 7.22; 3.94

Stock price statisticsIndustry

52-Week High: $48.25; –
52-Week Low: $19.16; –
20-Day Moving Average: $22.60; –
50-Day Moving Average: $23.02; –
200-Day Moving Average: $28.45; –
Average True Range (14): $1.51; –
Price Change (1 Week): -23.4%; 1.87%
Price Change (1 Month): -9.89%; -0.57%
Price Change (3 Months): -33.4%; -7.91%
Price Change (6 Months): -15.4%; -0.90%
Price Change (YTD): -57.5%; -0.87%
Price Change (1 Year): -58.6%; -1.18%
Price Change (3 Years): 43.0%; 6.56%
Price Change (5 Years): -4.15%; -49.8%
Price Change (10 Years): 2.65%; 72.9%
Average Volume (10 Days): 1M; –
Average Volume (20 Days): 804,863; –
Average Volume (90 Days): 663,670; –
Relative Volume: 1.29; 0.82
Relative Strength Index (14): 36.0; 47.7
Volatility (1 Year): 54.0%; 64.2%
Beta (5 Years): 1.15; 1.04

MarginsIndustry

Gross Margin: 63.3%; 55.9%
Operating Margin: 2.29%; -5.17%
Pretax Margin: -2.23%; -2.55%
Profit Margin: -3.65%; -9.23%
EBITDA Margin: 7.73%; -2.82%
FCF Margin: -9.21%; 0.40%

Returns on capitalIndustry

Return on Equity (ROE): -3.98%; -17.1%
Return on Assets (ROA): -1.85%; -12.2%
Return on Invested Capital (ROIC): 1.30%; -3.22%
Return on Capital Employed (ROCE): 1.14%; -8.13%

Financial positionIndustry

Current Ratio: 4.42; 2.45
Quick Ratio: 1.87; 1.53
Debt / Equity: 0.81; 0.42
Debt / EBITDA: 9.77; 2.19
Net Debt / EBITDA: 8.47; 1.53
Interest Coverage: 0.41; -1.68

GrowthIndustry

Revenue Growth (YoY): 14.0%; 9.24%
FCF Growth (YoY): -353.6%; 7.64%
Revenue Growth (3Y CAGR): 12.0%; 7.08%
Revenue Growth (5Y CAGR): 11.8%; 11.8%

EfficiencyIndustry

Asset Turnover: 0.51; 0.59
Inventory Turnover: 1.79; 2.20
Revenue Per Employee: $267.71K; $330.60K
Profits Per Employee: -$9.77K; -$41.39K
Employee Count: 1,800; 186
WACC: 9.35%; 9.79%

Income statement (TTM)Industry

Revenue: $481.88M; $106.81M
Gross Profit: $305.09M; $62.29M
Operating Income: $11.05M; -$3.72M
Pretax Income: -$10.74M; -$1.69M
Net Income: -$17.59M; -$6.19M
EBITDA: $37.24M; -$1.98M
EPS (Diluted): -$0.36; -$0.08

Balance sheetIndustry

Cash & Short-Term Investments: $48.40M; $38.08M
Total Debt: $363.79M; $96.00M
Net Cash (Debt): -$315.39M; $3.73M
Net Cash Per Share: -$6.47; $0.24
Equity (Book Value): $446.40M; $63.44M
Book Value Per Share: $9.16; $3.26
Tangible Book Value: -$44.46M; $11.04M
Working Capital: $262.16M; $56.85M

Cash flow (TTM)Industry

Operating Cash Flow: $14.89M; -$541.49K
Capital Expenditures: -$59.27M; -$3.69M
Free Cash Flow: -$44.38M; -$387.37K
FCF Per Share: -$0.91; -$0.01

Dividends and yieldsIndustry

Earnings Yield: -1.86%; -4.70%
FCF Yield: -4.69%; 0.24%
Buyback Yield: -0.80%; 0.79%
Shareholder Yield: -0.80%; 1.05%

Taxes and interestIndustry

Interest Expense: $26.67M; $5.33M
Income Tax: $6.85M; $1.63M

Scores and fair valueIndustry

Altman Z-Score: 1.66; 2.44
Piotroski F-Score: 7; 5
Beneish M-Score: -2.44; -2.64

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

Period	AORT	S&P 500	Difference	AORT per year	S&P 500 per year
1 month	-11.0%	-2.7%	−8.3 pts
3 months	-32.3%	-1.7%	−30.5 pts
Year to date	-57.5%	+11.9%	−69.4 pts
1 year	-59.3%	+12.0%	−71.3 pts
3 years	+45.5%	+78.2%	−32.6 pts	+13.3%	+21.2%
5 years	-4.2%	+73.2%	−77.4 pts	-0.8%	+11.6%
10 years	+2.6%	+309.6%	−307.0 pts	+0.3%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

3M AORT shares were sold short on Oct 30, 2026, down 8.6% from the previous report, or 7.68% of the shares available to trade. At recent volumes it would take 7.2 days to buy them back. Over the last 20 sessions, 56.4% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	3,412,435	-8.6%	472,904	7.2
Oct 15, 2026	3,735,523	+3.1%	517,233	7.2
Sep 30, 2026	3,621,461	+10.3%	654,874	5.5
Sep 15, 2026	3,284,198	+12.2%	604,535	5.4
Aug 31, 2026	2,927,038	+6.6%	662,170	4.4
Aug 14, 2026	2,745,747	+1.5%	857,370	3.2
Jul 31, 2026	2,705,501	+8.3%	568,148	4.8
Jul 15, 2026	2,498,637	+14.6%	550,079	4.5
Jun 30, 2026	2,179,918	+15.4%	1,075,389	2.0
Jun 15, 2026	1,888,924	-1.5%	810,012	2.3
May 29, 2026	1,917,337	-1.3%	679,115	2.8
May 15, 2026	1,942,065	+1.1%	1,140,219	1.7